Ocular Therapeutix Inc (OCUL)
8.74
+0.22
(+2.58%)
USD |
NASDAQ |
Nov 22, 14:33
Ocular Therapeutix Shareholders Equity (Quarterly): 352.02M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 352.02M |
| June 30, 2024 | 377.70M |
| March 31, 2024 | 407.98M |
| December 31, 2023 | 91.13M |
| September 30, 2023 | 7.853M |
| June 30, 2023 | 3.087M |
| March 31, 2023 | 9.711M |
| December 31, 2022 | 35.38M |
| September 30, 2022 | 46.23M |
| June 30, 2022 | 65.80M |
| March 31, 2022 | 79.80M |
| December 31, 2021 | 88.00M |
| September 30, 2021 | 87.34M |
| June 30, 2021 | 80.25M |
| March 31, 2021 | 83.41M |
| December 31, 2020 | 76.10M |
| September 30, 2020 | -4.126M |
| June 30, 2020 | 5.344M |
| March 31, 2020 | -10.66M |
| December 31, 2019 | -3.63M |
| September 30, 2019 | 11.30M |
| June 30, 2019 | 8.258M |
| Date | Value |
|---|---|
| March 31, 2019 | 25.65M |
| December 31, 2018 | 35.88M |
| September 30, 2018 | 45.52M |
| June 30, 2018 | 45.73M |
| March 31, 2018 | 49.18M |
| December 31, 2017 | 26.15M |
| September 30, 2017 | 35.92M |
| June 30, 2017 | 48.02M |
| March 31, 2017 | 63.90M |
| December 31, 2016 | 52.01M |
| September 30, 2016 | 62.29M |
| June 30, 2016 | 70.45M |
| March 31, 2016 | 80.17M |
| December 31, 2015 | 89.59M |
| September 30, 2015 | 98.81M |
| June 30, 2015 | 109.11M |
| March 31, 2015 | 52.07M |
| December 31, 2014 | 58.70M |
| September 30, 2014 | 65.60M |
| June 30, 2014 | -69.44M |
| March 31, 2014 | 11.15M |
| December 31, 2013 | -59.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.66M
Minimum
Mar 2020
407.98M
Maximum
Mar 2024
93.94M
Average
70.95M
Median
Shareholders Equity (Quarterly) Benchmarks
| 4D Molecular Therapeutics Inc | 552.95M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.37M |
| Total Liabilities (Quarterly) | 138.35M |
| Debt to Equity Ratio | 0.1926 |
| Current Ratio | 13.01 |
| Net Debt Paydown Yield | -0.18% |